Literature DB >> 11286306

Cardiac energetics during ischaemia and the rationale for metabolic interventions.

W C Stanley1.   

Abstract

Cardiac work is supported by high rates of combustion of carbon fuel and oxygen consumption. Fatty acids are the main fuel for the healthy heart, supplying approximately 60-80% of the energy. The balance of the energy comes from the oxidation of glucose and lactate. ATP is broken down to fuel contractile work. ATP is resynthesized in the mitochondria using energy from the oxidation of fatty acids, glucose, and lactate. Myocardial ischaemia dramatically alters fuel metabolism. Ischaemia occurs when the coronary blood flow is insufficient to supply enough oxygen to combust carbon fuels and resynthesize ATP at the normal rate. During partial reductions in coronary blood flow (30-60% of normal) there is a proportional decrease in the rates of oxygen consumption and production of ATP, and an increase in uptake of glucose by the heart. However, unlike under normal aerobic conditions, the glucose taken up by the ischaemic myocardium is not readily oxidized in the mitochondria, but rather is converted to lactate and there is a switch from uptake of lactate by the heart to lactate production. This causes a dramatic disruption in cell homeostasis: ATP content decreases; there is accumulation of lactate and H+, a fall in intracellular pH and a decrease in contractile work. Paradoxically, the ischaemic tissue continues to derive most of its energy (50-70%) from the oxidation of fatty acids despite there being a high rate of lactate production. This ischaemia-induced disruption of cardiac metabolism can be minimized by metabolic agents that decrease oxidation of fatty acids and increase the rates of combustion of glucose and lactate, resulting in clinical benefit to the ischaemic patient.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11286306

Source DB:  PubMed          Journal:  Coron Artery Dis        ISSN: 0954-6928            Impact factor:   1.439


  13 in total

1.  Myocardial kinetics of Tc-99m glucarate in low flow, hypoxia, and aglycemia.

Authors:  D R Okada; G Johnson; Z Liu; S D Hocherman; B A Khaw; K Y Pak; R D Okada
Journal:  J Nucl Cardiol       Date:  2003 Mar-Apr       Impact factor: 5.952

Review 2.  Metabolic approaches to the treatment of ischemic heart disease: the clinicians' perspective.

Authors:  Andrew A Wolff; Heschi H Rotmensch; William C Stanley; Roberto Ferrari
Journal:  Heart Fail Rev       Date:  2002-04       Impact factor: 4.214

3.  Pre-clinical myocardial metabolic alterations in chronic kidney disease.

Authors:  Jeffrey C Fink; Martin A Lodge; Mark F Smith; Anish Hinduja; Jeanine Brown; Mara Y Dinits-Pensy; Vasken Dilsizian
Journal:  Cardiology       Date:  2010-07-07       Impact factor: 1.869

4.  Similar patterns of myocardial metabolism and perfusion in patients with type 2 diabetes and heart disease of ischaemic and non-ischaemic origin.

Authors:  S Masi; R Lautamäki; L Guiducci; P Di Cecco; C Porciello; S Pardini; M A Morales; V Chubuchny; P A Salvadori; M Emdin; A M Sironi; J Knuuti; D Neglia; P Nuutila; E Ferrannini; P Iozzo
Journal:  Diabetologia       Date:  2012-07-01       Impact factor: 10.122

Review 5.  Biochemical dysfunction in heart mitochondria exposed to ischaemia and reperfusion.

Authors:  Giancarlo Solaini; David A Harris
Journal:  Biochem J       Date:  2005-09-01       Impact factor: 3.857

6.  Salvage of nicotinamide adenine dinucleotide plays a critical role in the bioenergetic recovery of post-hypoxic cardiomyocytes.

Authors:  Domokos Gero; Csaba Szabo
Journal:  Br J Pharmacol       Date:  2015-10-14       Impact factor: 8.739

7.  Transmural distribution of metabolic abnormalities and glycolytic activity during dobutamine-induced demand ischemia.

Authors:  Mohammad N Jameel; Xiaohong Wang; Marcel H J Eijgelshoven; Abdul Mansoor; Jianyi Zhang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-04-18       Impact factor: 4.733

8.  Feeding the fibrillating heart: Dichloroacetate improves cardiac contractile dysfunction following VF.

Authors:  Mohammed Ali Azam; Cory S Wagg; Stéphane Massé; Talha Farid; Patrick F H Lai; Marjan Kusha; John Asta; Rafael Jaimes; Sarah Kuzmiak-Glancy; Matthew W Kay; Gary D Lopaschuk; Kumaraswamy Nanthakumar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-09-04       Impact factor: 4.733

9.  Dynamic analysis of optimality in myocardial energy metabolism under normal and ischemic conditions.

Authors:  Ruo-Yu Luo; Sha Liao; Guan-Yang Tao; Yuan-Yuan Li; Shaoqun Zeng; Yi-Xue Li; Qingming Luo
Journal:  Mol Syst Biol       Date:  2006-06-06       Impact factor: 11.429

10.  Turbina oblongata Protects Against Oxidative Cardiotoxicity by Suppressing Lipid Dysmetabolism and Modulating Cardiometabolic Activities Linked to Cardiac Dysfunctions.

Authors:  Ochuko L Erukainure; Chika I Chukwuma; Motlalepula G Matsabisa; Mirranda T Javu; Veronica F Salau; Neil A Koorbanally; Md Shahidul Islam
Journal:  Front Pharmacol       Date:  2021-05-20       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.